The multiple roles of the cyclin-dependent kinase inhibitory protein p57 KIP2 in cerebral cortical neurogenesis

Developmental Neurobiology

Volumn 72, Issue 6, 2012, Pages 821-842

  Tury, Anna ^a,c   Mairet Coello, Georges ^a,d   Dicicco Bloom, Emanuel ^a,b  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Cell cycle exit; Cell fate; Cerebral cortex; Differentiation; Migration; P27 KIP1; Proliferation

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1C;

ARTICLE; BRAIN CORTEX; CELL CYCLE PROGRESSION; CELL DEATH; CELL DIFFERENTIATION; CELL FATE; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; COMPLEX FORMATION; HUMAN; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; CELL CYCLE; CELL MOVEMENT; CELL SURVIVAL; CEREBRAL CORTEX; CYCLIN-DEPENDENT KINASE INHIBITOR P57; NEUROGENESIS; NEURONS;

EID: 84860896835     PISSN: 19328451     EISSN: 10974695     Source Type: Journal    
DOI: 10.1002/dneu.20999     Document Type: Article

References (170)

1. Aktas H, Cai H, Cooper GM. 1997. Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1. Mol Cell Biol 17: 3850-3857.
2. Algar EM, Muscat A, Dagar V, Rickert C, Chow CW, Biegel JA, Ekert PG, et al. 2009. Imprinted CDKN1C is a tumor suppressor in rhabdoid tumor and activated by restoration of SMARCB1 and histone deacetylase inhibitors. PLoS One 4: e4482.
3. Amrein L, Barraud P, Daniel JY, Perel Y, Landry M. 2005. Expression patterns of nm23 genes during mouse organogenesis. Cell Tissue Res 322: 365-378.
4. Angevine JBJr, Sidman RL. 1961. Autoradiographic study of cell migration during histogenesis of cerebral cortex in the mouse. Nature 192: 766-768.
5. Arai Y, Pulvers JN, Haffner C, Schilling B, Nusslein I, Calegari F, Huttner WB. 2011. Neural stem and progenitor cells shorten S-phase on commitment to neuron production. Nat Commun 2: 154.
6. Arnold SJ, Huang GJ, Cheung AF, Era T, Nishikawa S, Bikoff EK, Molnar Z, et al. 2008. The T-box transcription factor Eomes/Tbr2 regulates neurogenesis in the cortical subventricular zone. Genes Dev 22: 2479-2484.
7. Baba H, Urano T, Okada K, Furukawa K, Nakayama E, Tanaka H, Iwasaki K, et al. 1995. Two isotypes of murine nm23/nucleoside diphosphate kinase, nm23-M1 and nm23-M2, are involved in metastatic suppression of a murine melanoma line. Cancer Res 55: 1977-1981.
8. Baldassarre G, Belletti B, Nicoloso MS, Schiappacassi M, Vecchione A, Spessotto P, Morrione A, et al. 2005. p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion. Cancer Cell 7: 51-63.
9. Bayer SA, Altman J. 1991. Neocortical Development. New York: Raven Press.
10. Belletti B, Pellizzari I, Berton S, Fabris L, Wolf K, Lovat F, Schiappacassi M, et al. 2010. p27kip1 controls cell morphology and motility by regulating microtubule-dependent lipid raft recycling. Mol Cell Biol 30: 2229-2240.
11. Beretta C, Chiarelli A, Testoni B, Mantovani R, Guerrini L. 2005. Regulation of the cyclin-dependent kinase inhibitor p57Kip2 expression by p63. Cell Cycle 4: 1625-1631.
12. Berry M, Rogers AW, Eayrs JT. 1964. Pattern of cell migration during cortical histogenesis. Nature 203: 591-593.
13. Besson A, Assoian RK, Roberts JM. 2004a. Regulation of the cytoskeleton: An oncogenic function for CDK inhibitors? Nat Rev Cancer 4: 948-955.
14. Besson A, Dowdy SF, Roberts JM. 2008. CDK inhibitors: Cell cycle regulators and beyond. Dev Cell 14: 159-169.
15. Besson A, Gurian-West M, Schmidt A, Hall A, Roberts JM. 2004b. p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev 18: 862-876.
16. Bilodeau S, Roussel-Gervais A, Drouin J. 2009. Distinct developmental roles of cell cycle inhibitors p57Kip2 and p27Kip1 distinguish pituitary progenitor cell cycle exit from cell cycle reentry of differentiated cells. Mol Cell Biol 29: 1895-1908.
17. Blint E, Phillips AC, Kozlov S, Stewart CL, Vousden KH. 2002. Induction of p57(KIP2) expression by p73beta. Proc Natl Acad Sci USA 99: 3529-3534.
18. Calegari F, Haubensak W, Haffner C, Huttner WB. 2005. Selective lengthening of the cell cycle in the neurogenic subpopulation of neural progenitor cells during mouse brain development. J Neurosci 25: 6533-6538.
19. Calegari F, Huttner WB. 2003. An inhibition of cyclin-dependent kinases that lengthens, but does not arrest, neuroepithelial cell cycle induces premature neurogenesis. J Cell Sci 116: 4947-4955.
20. Carey RG, Li B, DiCicco-Bloom E. 2002. Pituitary adenylate cyclase activating polypeptide anti-mitogenic signaling in cerebral cortical progenitors is regulated by p57Kip2-dependent CDK2 activity. J Neurosci 22: 1583-1591.
21. Carotenuto P, Marino N, Bello AM, D'Angelo A, Di Porzio U, Lombardi D, Zollo M. 2006. PRUNE and NM23-M1 expression in embryonic and adult mouse brain. J Bioenerg Biomembr 38: 233-246.
22. Carruthers S, Mason J, Papalopulu N. 2003. Depletion of the cell-cycle inhibitor p27(Xic1) impairs neuronal differentiation and increases the number of ElrC(+) progenitor cells in Xenopus tropicalis. Mech Dev 120: 607-616.
23. Casaccia-Bonnefil P, Tikoo R, Kiyokawa H, Friedrich VJr, Chao MV, Koff A. 1997. Oligodendrocyte precursor differentiation is perturbed in the absence of the cyclin-dependent kinase inhibitor p27Kip1. Genes Dev 11: 2335-2346.
24. Caviness VS, Bhide PG, Nowakowski RS. 2008. Histogenetic processes leading to the laminated neocortex: Migration is only a part of the story. Dev Neurosci 30: 82-95.
25. Caviness VSJr, Takahashi T, Nowakowski RS. 1995. Numbers, time and neocortical neuronogenesis: A general developmental and evolutionary model. Trends Neurosci 18: 379-383.
26. Chang TS, Kim MJ, Ryoo K, Park J, Eom SJ, Shim J, Nakayama KI, et al. 2003. p57KIP2 modulates stress-activated signaling by inhibiting c-Jun NH2-terminal kinase/stress-activated protein Kinase. J Biol Chem 278: 48092-48098.
27. Cunningham JJ, Roussel MF. 2001. Cyclin-dependent kinase inhibitors in the development of the central nervous system. Cell Growth Differ 12: 387-396.
28. Dabernat S, Larou M, Masse K, Hokfelt T, Mayer G, Daniel JY, Landry M. 1999. Cloning of a second nm23-M1 cDNA: Expression in the central nervous system of adult mouse and comparison with nm23-M2 mRNA distribution. Brain Res Mol Brain Res 63: 351-365.
29. Daniels M, Dhokia V, Richard-Parpaillon L, Ohnuma S. 2004. Identification of Xenopus cyclin-dependent kinase inhibitors, p16Xic2 and p17Xic3. Gene 342: 41-47.
30. Davila M, Frost AR, Grizzle WE, Chakrabarti R. 2003. LIM kinase 1 is essential for the invasive growth of prostate epithelial cells: implications in prostate cancer. J Biol Chem 278: 36868-36875.
31. Delalle I, Takahashi T, Nowakowski RS, Tsai LH, Caviness VSJr. 1999. Cyclin E-p27 opposition and regulation of the G1 phase of the cell cycle in the murine neocortical PVE: A quantitative analysis of mRNA in situ hybridization. Cereb Cortex 9: 824-832.
32. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P. 1995. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675-684.
33. Dugas JC, Ibrahim A, Barres BA. 2007. A crucial role for p57(Kip2) in the intracellular timer that controls oligodendrocyte differentiation. J Neurosci 27: 6185-6196.
34. Durand B, Gao FB, Raff M. 1997. Accumulation of the cyclin-dependent kinase inhibitor p27/Kip1 and the timing of oligodendrocyte differentiation. EMBO J 16: 306-317.
35. Dyer MA, Cepko CL. 2000. p57(Kip2) regulates progenitor cell proliferation and amacrine interneuron development in the mouse retina. Development 127: 3593-3605.
36. Dyer MA, Cepko CL. 2001a. p27Kip1 and p57Kip2 regulate proliferation in distinct retinal progenitor cell populations. J Neurosci 21: 4259-4271.
37. Dyer MA, Cepko CL. 2001b. The p57Kip2 cyclin kinase inhibitor is expressed by a restricted set of amacrine cells in the rodent retina. J Comp Neurol 429: 601-614.
38. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, et al. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
39. El Kharroubi A, Piras G, Stewart CL. 2001. DNA demethylation reactivates a subset of imprinted genes in uniparental mouse embryonic fibroblasts. J Biol Chem 276: 8674-8680.
40. Englund C, Fink A, Lau C, Pham D, Daza RA, Bulfone A, Kowalczyk T, et al. 2005. Pax6, Tbr2, and Tbr1 are expressed sequentially by radial glia, intermediate progenitor cells, and postmitotic neurons in developing neocortex. J Neurosci 25: 247-251.
41. Faigle R, Liu L, Cundiff P, Funa K, Xia Z. 2008. Opposing effects of retinoid signaling on astrogliogenesis in embryonic day 13 and 17 cortical progenitor cells. J Neurochem 106: 1681-1698.
42. Farkas LM, Huttner WB. 2008. The cell biology of neural stem and progenitor cells and its significance for their proliferation versus differentiation during mammalian brain development. Curr Opin Cell Biol 20: 707-715.
43. Fero ML, Rivkin M, Tasch M, Porter P, Carow CE, Firpo E, Polyak K, et al. 1996. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 85: 733-744.
44. Fish JL, Dehay C, Kennedy H, Huttner WB. 2008. Making bigger brains-The evolution of neural-progenitor-cell division. J Cell Sci 121: 2783-2793.
45. Fornari F, Gramantieri L, Ferracin M, Veronese A, Sabbioni S, Calin GA, Grazi GL, et al. 2008. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene 27: 5651-5661.
46. Franklin DS, Godfrey VL, Lee H, Kovalev GI, Schoonhoven R, Chen-Kiang S, Su L, et al. 1998. CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes Dev 12: 2899-2911.
47. Ge W, He F, Kim KJ, Blanchi B, Coskun V, Nguyen L, Wu X, et al. 2006. Coupling of cell migration with neurogenesis by proneural bHLH factors. Proc Natl Acad Sci USA 103: 1319-1324.
48. Georgia S, Soliz R, Li M, Zhang P, Bhushan A. 2006. p57 and Hes1 coordinate cell cycle exit with self-renewal of pancreatic progenitors. Dev Biol 298: 22-31.
49. Gervasi F, D'Agnano I, Vossio S, Zupi G, Sacchi A, Lombardi D. 1996. nm23 influences proliferation and differentiation of PC12 cells in response to nerve growth factor. Cell Growth Differ 7: 1689-1695.
50. Glickstein SB, Monaghan JA, Koeller HB, Jones TK, Ross ME. 2009. Cyclin D2 is critical for intermediate progenitor cell proliferation in the embryonic cortex. J Neurosci 29: 9614-9624.
51. Goto T, Mitsuhashi T, Takahashi T. 2004. Altered patterns of neuron production in the p27 knockout mouse. Dev Neurosci 26: 208-217.
52. Gotz M, Huttner WB. 2005. The cell biology of neurogenesis. Nat Rev Mol Cell Biol 6: 777-788.
53. Gotz M, Stoykova A, Gruss P. 1998. Pax6 controls radial glia differentiation in the cerebral cortex. Neuron 21: 1031-1044.
54. Gu Y, Turck CW, Morgan DO. 1993. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366: 707-710.
55. Gui H, Li S, Matise MP. 2007. A cell-autonomous requirement for Cip/Kip cyclin-kinase inhibitors in regulating neuronal cell cycle exit but not differentiation in the developing spinal cord. Dev Biol 301: 14-26.
56. Guillemot F, Joyner AL. 1993. Dynamic expression of the murine Achaete-Scute homologue Mash-1 in the developing nervous system. Mech Dev 42: 171-185.
57. Guo H, Tian T, Nan K, Wang W. 2010. p57: A multifunctional protein in cancer (review). Int J Oncol 36: 1321-1329.
58. Hack MA, Sugimori M, Lundberg C, Nakafuku M, Gotz M. 2004. Regionalization and fate specification in neurospheres: the role of Olig2 and Pax6. Mol Cell Neurosci 25: 664-678.
59. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816.
60. Hatada I, Inazawa J, Abe T, Nakayama M, Kaneko Y, Jinno Y, Niikawa N, et al. 1996a. Genomic imprinting of human p57KIP2 and its reduced expression in Wilms' tumors. Hum Mol Genet 5: 783-788.
61. Hatada I, Mukai T. 1995. Genomic imprinting of p57KIP2, a cyclin-dependent kinase inhibitor, in mouse. Nat Genet 11: 204-206.
62. Hatada I, Ohashi H, Fukushima Y, Kaneko Y, Inoue M, Komoto Y, Okada A, et al. 1996b. An imprinted gene p57KIP2 is mutated in Beckwith-Wiedemann syndrome. Nat Genet 14: 171-173.
63. Haubensak W, Attardo A, Denk W, Huttner WB. 2004. Neurons arise in the basal neuroepithelium of the early mammalian telencephalon: a major site of neurogenesis. Proc Natl Acad Sci USA 101: 3196-3201.
64. Heinen A, Kremer D, Gottle P, Kruse F, Hasse B, Lehmann H, Hartung HP, et al. 2008a. The cyclin-dependent kinase inhibitor p57kip2 is a negative regulator of Schwann cell differentiation and in vitro myelination. Proc Natl Acad Sci USA 105: 8748-8753.
65. Heinen A, Kremer D, Hartung HP, Kury P. 2008b. p57 kip2's role beyond Schwann cell cycle control. Cell Cycle 7: 2781-2786.
66. Hicks SP, D'Amato CJ. 1968. Cell migrations to the isocortex in the rat. Anat Rec 160: 619-634.
67. Higashimoto K, Soejima H, Saito T, Okumura K, Mukai T. 2006. Imprinting disruption of the CDKN1C/KCNQ1OT1 domain: The molecular mechanisms causing Beckwith-Wiedemann syndrome and cancer. Cytogenet Genome Res 113: 306-312.
68. Huttner WB, Kosodo Y. 2005. Symmetric versus asymmetric cell division during neurogenesis in the developing vertebrate central nervous system. Curr Opin Cell Biol 17: 648-657.
69. Itoh Y, Masuyama N, Nakayama K, Nakayama KI, Gotoh Y. 2007. The cyclin-dependent kinase inhibitors p57 and p27 regulate neuronal migration in the developing mouse neocortex. J Biol Chem 282: 390-396.
70. Jia J, Lin M, Zhang L, York JP, Zhang P. 2007. The Notch signaling pathway controls the size of the ocular lens by directly suppressing p57Kip2 expression. Mol Cell Biol 27: 7236-7247.
71. Joseph B, Andersson ER, Vlachos P, Sodersten E, Liu L, Teixeira AI, Hermanson O. 2009. p57Kip2 is a repressor of Mash1 activity and neuronal differentiation in neural stem cells. Cell Death Differ 16: 1256-1265.
72. Joseph B, Hermanson O. 2010. Molecular control of brain size: Regulators of neural stem cell life, death and beyond. Exp Cell Res 316: 1415-1421.
73. Joseph B, Wallen-Mackenzie A, Benoit G, Murata T, Joodmardi E, Okret S, Perlmann T. 2003. p57(Kip2) cooperates with Nurr1 in developing dopamine cells. Proc Natl Acad Sci USA 100: 15619-15624.
74. Kamura T, Hara T, Kotoshiba S, Yada M, Ishida N, Imaki H, Hatakeyama S, et al. 2003. Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation. Proc Natl Acad Sci USA 100: 10231-10236.
75. Kavanagh E, Joseph B. 2011. The hallmarks of CDKN1C (p57, KIP2) in cancer. Biochim Biophys Acta 1816: 50-56.
76. Kawauchi T, Chihama K, Nabeshima Y, Hoshino M. 2006. Cdk5 phosphorylates and stabilizes p27kip1 contributing to actin organization and cortical neuronal migration. Nat Cell Biol 8: 17-26.
77. Kim YK, Yu J, Han TS, Park SY, Namkoong B, Kim DH, Hur K, et al. 2009. Functional links between clustered microRNAs: Suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res 37: 1672-1681.
78. Kippin TE, Martens DJ, van der Kooy D. 2005. p21 loss compromises the relative quiescence of forebrain stem cell proliferation leading to exhaustion of their proliferation capacity. Genes Dev 19: 756-767.
79. Kremer D, Heinen A, Jadasz J, Gottle P, Zimmermann K, Zickler P, Jander S, et al. 2009. p57kip2 is dynamically regulated in experimental autoimmune encephalomyelitis and interferes with oligodendroglial maturation. Proc Natl Acad Sci USA 106: 9087-9092.
80. Kriegstein A, Noctor S, Martinez-Cerdeno V. 2006. Patterns of neural stem and progenitor cell division may underlie evolutionary cortical expansion. Nat Rev Neurosci 7: 883-890.
81. Krimpenfort P, Quon KC, Mooi WJ, Loonstra A, Berns A. 2001. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature 413: 83-86.
82. Lam WW, Hatada I, Ohishi S, Mukai T, Joyce JA, Cole TR, Donnai D, et al. 1999. Analysis of germline CDKN1C (p57KIP2) mutations in familial and sporadic Beckwith-Wiedemann syndrome (BWS) provides a novel genotype-phenotype correlation. J Med Genet 36: 518-523.
83. Lange C, Huttner WB, Calegari F. 2009. Cdk4/cyclinD1 overexpression in neural stem cells shortens G1, delays neurogenesis, and promotes the generation and expansion of basal progenitors. Cell Stem Cell 5: 320-331.
84. Latres E, Malumbres M, Sotillo R, Martin J, Ortega S, Martin-Caballero J, Flores JM, et al. 2000. Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis. EMBO J 19: 3496-3506.
85. Le TT, Wroblewski E, Patel S, Riesenberg AN, Brown NL. 2006. Math5 is required for both early retinal neuron differentiation and cell cycle progression. Dev Biol 295: 764-778.
86. Lee MH, Reynisdottir I, Massague J. 1995. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 9: 639-649.
87. Lee S, Helfman DM. 2004. Cytoplasmic p21Cip1 is involved in Ras-induced inhibition of the ROCK/LIMK/cofilin pathway. J Biol Chem 279: 1885-1891.
88. Li B, DiCicco-Bloom E. 2004. Basic fibroblast growth factor exhibits dual and rapid regulation of cyclin D1 and p27 to stimulate proliferation of rat cerebral cortical precursors. Dev Neurosci 26: 197-207.
89. Lo LC, Johnson JE, Wuenschell CW, Saito T, Anderson DJ. 1991. Mammalian achaete-scute homolog 1 is transiently expressed by spatially restricted subsets of early neuroepithelial and neural crest cells. Genes Dev 5: 1524-1537.
90. Lukaszewicz A, Savatier P, Cortay V, Giroud P, Huissoud C, Berland M, Kennedy H, et al. 2005. G1 phase regulation, area-specific cell cycle control, and cytoarchitectonics in the primate cortex. Neuron 47: 353-364.
91. Lukaszewicz A, Savatier P, Cortay V, Kennedy H, Dehay C. 2002. Contrasting effects of basic fibroblast growth factor and neurotrophin 3 on cell cycle kinetics of mouse cortical stem cells. J Neurosci 22: 6610-6622.
92. MacLean HE, Guo J, Knight MC, Zhang P, Cobrinik D, Kronenberg HM. 2004. The cyclin-dependent kinase inhibitor p57(Kip2) mediates proliferative actions of PTHrP in chondrocytes. J Clin Invest 113: 1334-1343.
93. Mairet-Coello G, Tury A, DiCicco-Bloom E. 2009. The Cyclin-Dependent Kinase Inhibitor p57KIP2 Regulates G1 Phase Length in Cerebral Cortical Precursors and Restricts Cell Production in Developing Mouse Neocortex. Chicago: The Society for Neuroscience.
94. Mairet-Coello G, Tury A, Van Buskirk E, Robinson K, Genestine M, DiCicco-Bloom E. 2012. p57KIP2 regulates radial glia and intermediate precursor cell cycle dynamics and lower layer neurogenesis in developing cerebral cortex. Development 139: 475-487.
95. Marino N, Marshall JC, Steeg PS. 2011. Protein-protein interactions: A mechanism regulating the anti-metastatic properties of Nm23-H1. Naunyn Schmiedebergs Arch Pharmacol 384: 351-362.
96. Marshall JC, Collins J, Marino N, Steeg P. 2010. The Nm23-H1 metastasis suppressor as a translational target. Eur J Cancer 46: 1278-1282.
97. Martinez-Cerdeno V, Noctor SC, Kriegstein AR. 2006. The role of intermediate progenitor cells in the evolutionary expansion of the cerebral cortex. Cereb Cortex 16( Suppl 1): i152-i161.
98. Matsuoka S, Edwards MC, Bai C, Parker S, Zhang P, Baldini A, Harper JW, et al. 1995. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 9: 650-662.
99. Matsuoka S, Thompson JS, Edwards MC, Bartletta JM, Grundy P, Kalikin LM, Harper JW, et al. 1996. Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15. Proc Natl Acad Sci USA 93: 3026-3030.
100. McConnell SK. 1988. Development and decision-making in the mammalian cerebral cortex. Brain Res 472: 1-23.
101. McConnell SK. 1995. Constructing the cerebral cortex: Neurogenesis and fate determination. Neuron 15: 761-768.
102. Medina R, Zaidi SK, Liu CG, Stein JL, van Wijnen AJ, Croce CM, Stein GS. 2008. MicroRNAs 221 and 222 bypass quiescence and compromise cell survival. Cancer Res 68: 2773-2780.
103. Miller FD, Gauthier AS. 2007. Timing is everything: Making neurons versus glia in the developing cortex. Neuron 54: 357-369.
104. Miyata T, Kawaguchi A, Saito K, Kawano M, Muto T, Ogawa M. 2004. Asymmetric production of surface-dividing and non-surface-dividing cortical progenitor cells. Development 131: 3133-3145.
105. Mochizuki T, Bilitou A, Waters CT, Hussain K, Zollo M, Ohnuma S. 2009. Xenopus NM23-X4 regulates retinal gliogenesis through interaction with p27Xic1. Neural Dev 4: 1.
106. Nagahama H, Hatakeyama S, Nakayama K, Nagata M, Tomita K. 2001. Spatial and temporal expression patterns of the cyclin-dependent kinase (CDK) inhibitors p27Kip1 and p57Kip2 during mouse development. Anat Embryol (Berl) 203: 77-87.
107. Nguyen L, Besson A, Heng JI, Schuurmans C, Teboul L, Parras C, Philpott A, et al. 2006. p27kip1 independently promotes neuronal differentiation and migration in the cerebral cortex. Genes Dev 20: 1511-1524.
108. Noctor SC, Martinez-Cerdeno V, Ivic L, Kriegstein AR. 2004. Cortical neurons arise in symmetric and asymmetric division zones and migrate through specific phases. Nat Neurosci 7: 136-144.
109. Nourse J, Firpo E, Flanagan WM, Coats S, Polyak K, Lee MH, Massague J, et al. 1994. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372: 570-573.
110. O'Keefe D, Dao D, Zhao L, Sanderson R, Warburton D, Weiss L, Anyane-Yeboa K, et al. 1997. Coding mutations in p57KIP2 are present in some cases of Beckwith-Wiedemann syndrome but are rare or absent in Wilms tumors. Am J Hum Genet 61: 295-303.
111. Ohnuma S, Hopper S, Wang KC, Philpott A, Harris WA. 2002. Co-ordinating retinal histogenesis: Early cell cycle exit enhances early cell fate determination in the Xenopus retina. Development 129: 2435-2446.
112. Ohnuma S, Philpott A, Wang K, Holt CE, Harris WA. 1999. p27Xic1, a Cdk inhibitor, promotes the determination of glial cells in Xenopus retina. Cell 99: 499-510.
113. Osumi N, Shinohara H, Numayama-Tsuruta K, Maekawa M. 2008. Concise review: Pax6 transcription factor contributes to both embryonic and adult neurogenesis as a multifunctional regulator. Stem Cells 26: 1663-1672.
114. Park HC, Boyce J, Shin J, Appel B. 2005. Oligodendrocyte specification in zebrafish requires notch-regulated cyclin-dependent kinase inhibitor function. J Neurosci 25: 6836-6844.
115. Pateras IS, Apostolopoulou K, Niforou K, Kotsinas A, Gorgoulis VG. 2009. p57KIP2: "Kip"ing the cell under control. Mol Cancer Res 7: 1902-1919.
116. Pilaz LJ, Patti D, Marcy G, Ollier E, Pfister S, Douglas RJ, Betizeau M, et al. 2009. Forced G1-phase reduction alters mode of division, neuron number, and laminar phenotype in the cerebral cortex. Proc Natl Acad Sci USA 106: 21924-21929.
117. Polleux F, Dehay C, Kennedy H. 1997a. The timetable of laminar neurogenesis contributes to the specification of cortical areas in mouse isocortex. J Comp Neurol 385: 95-116.
118. Polleux F, Dehay C, Moraillon B, Kennedy H. 1997b. Regulation of neuroblast cell-cycle kinetics plays a crucial role in the generation of unique features of neocortical areas. J Neurosci 17: 7763-7783.
119. Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A. 1994a. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev 8: 9-22.
120. Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, Massague J. 1994b. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59-66.
121. Pontious A, Kowalczyk T, Englund C, Hevner RF. 2008. Role of intermediate progenitor cells in cerebral cortex development. Dev Neurosci 30: 24-32.
122. Qian K, Hu L, Chen H, Li H, Liu N, Li Y, Ai J, et al. 2009. Hsa-miR-222 is involved in differentiation of endometrial stromal cells in vitro. Endocrinology 150: 4734-4743.
123. Rakic P. 1988. Specification of cerebral cortical areas. Science 241: 170-176.
124. Rakic P. 1995. A small step for the cell, a giant leap for mankind: A hypothesis of neocortical expansion during evolution. Trends Neurosci 18: 383-388.
125. Reynaud EG, Leibovitch MP, Tintignac LA, Pelpel K, Guillier M, Leibovitch SA. 2000. Stabilization of MyoD by direct binding to p57(Kip2). J Biol Chem 275: 18767-18776.
126. Rosso S, Bollati F, Bisbal M, Peretti D, Sumi T, Nakamura T, Quiroga S, et al. 2004. LIMK1 regulates Golgi dynamics, traffic of Golgi-derived vesicles, and process extension in primary cultured neurons. Mol Biol Cell 15: 3433-3449.
127. Rothschild G, Zhao X, Iavarone A, Lasorella A. 2006. E Proteins and Id2 converge on p57Kip2 to regulate cell cycle in neural cells. Mol Cell Biol 26: 4351-4361.
128. Roussel MF. 1999. The INK4 family of cell cycle inhibitors in cancer. Oncogene 18: 5311-5317.
129. Roybon L, Mastracci TL, Ribeiro D, Sussel L, Brundin P, Li JY. 2010. GABAergic differentiation induced by Mash1 is compromised by the bHLH proteins Neurogenin2, NeuroD1, and NeuroD2. Cereb Cortex 20: 1234-1244.
130. Russo AA, Tong L, Lee JO, Jeffrey PD, Pavletich NP. 1998. Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a. Nature 395: 237-243.
131. Sansom SN, Griffiths DS, Faedo A, Kleinjan DJ, Ruan Y, Smith J, van Heyningen V, et al. 2009. The level of the transcription factor Pax6 is essential for controlling the balance between neural stem cell self-renewal and neurogenesis. PLoS Genet 5: e1000511.
132. Scandura JM, Boccuni P, Massague J, Nimer SD. 2004. Transforming growth factor beta-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation. Proc Natl Acad Sci USA 101: 15231-15236.
133. Schuurmans C, Armant O, Nieto M, Stenman JM, Britz O, Klenin N, Brown C, et al. 2004. Sequential phases of cortical specification involve neurogenin-dependent and -independent pathways. EMBO J 23: 2892-2902.
134. Sengupta S, Nie J, Wagner RJ, Yang C, Stewart R, Thomson JA. 2009. MicroRNA 92b controls the G1/S checkpoint gene p57 in human embryonic stem cells. Stem Cells 27: 1524-1528.
135. Sessa A, Mao C-A, Hadjantonakis A-K, Klein WH, Broccoli V. 2008. Tbr2 directs conversion of radial glia into basal precursors and guides neuronal amplification by indirect neurogenesis in the developing neocortex. Neuron 60: 56-69.
136. Sharpless NE, Bardeesy N, Lee KH, Carrasco D, Castrillon DH, Aguirre AJ, Wu EA, et al. 2001. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature 413: 86-91.
137. Sherr CJ, Roberts JM. 1999. CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev 13: 1501-1512.
138. Sun Y, Nadal-Vicens M, Misono S, Lin MZ, Zubiaga A, Hua X, Fan G, et al. 2001. Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms. Cell 104: 365-376.
139. Susaki E, Nakayama K, Yamasaki L, Nakayama KI. 2009. Common and specific roles of the related CDK inhibitors p27 and p57 revealed by a knock-in mouse model. Proc Natl Acad Sci USA 106: 5192-5197.
140. Suter B, Nowakowski RS, Bhide PG, Caviness VS. 2007. Navigating neocortical neurogenesis and neuronal specification: A positional information system encoded by neurogenetic gradients. J Neurosci 27: 10777-10784.
141. Takahashi T, Nowakowski RS, Caviness VSJr. 1995. The cell cycle of the pseudostratified ventricular epithelium of the embryonic murine cerebral wall. J Neurosci 15: 6046-6057.
142. Tanaka H, Yamashita T, Asada M, Mizutani S, Yoshikawa H, Tohyama M. 2002. Cytoplasmic p21(Cip1/WAF1) regulates neurite remodeling by inhibiting Rho-kinase activity. J Cell Biol 158: 321-329.
143. Tarui T, Takahashi T, Nowakowski RS, Hayes NL, Bhide PG, Caviness VS. 2005. Overexpression of p27 Kip 1, probability of cell cycle exit, and laminar destination of neocortical neurons. Cereb Cortex 15: 1343-1355.
144. Taverna E, Huttner WB. 2010. Neural progenitor nuclei IN motion. Neuron 67: 906-914.
145. Tokino T, Urano T, Furuhata T, Matsushima M, Miyatsu T, Sasaki S, Nakamura Y. 1996. Characterization of the human p57KIP2 gene: alternative splicing, insertion/deletion polymorphisms in VNTR sequences in the coding region, and mutational analysis. Hum Genet 97: 625-631.
146. Topark-Ngarm A, Golonzhka O, Peterson VJ, Barrett BJr, Martinez B, Crofoot K, Filtz TM, et al. 2006. CTIP2 associates with the NuRD complex on the promoter of p57KIP2, a newly identified CTIP2 target gene. J Biol Chem 281: 32272-32283.
147. Toyoshima H, Hunter T. 1994. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78: 67-74.
148. Tury A, Mairet-Coello G, DiCicco-Bloom E. 2011. The cyclin-dependent kinase inhibitor p57Kip2 regulates cell cycle exit, differentiation, and migration of embryonic cerebral cortical precursors. Cereb Cortex 21: 1840-1856.
149. Vaccarello G, Figliola R, Cramerotti S, Novelli F, Maione R. 2006. p57Kip2 is induced by MyoD through a p73-dependent pathway. J Mol Biol 356: 578-588.
150. van Lookeren Campagne M, Gill R. 1998. Tumor-suppressor p53 is expressed in proliferating and newly formed neurons of the embryonic and postnatal rat brain: Comparison with expression of the cell cycle regulators p21Waf1/Cip1, p27Kip1, p57Kip2, p16Ink4a, cyclin G1, and the proto-oncogene Bax. J Comp Neurol 397: 181-198.
151. Vernon AE, Devine C, Philpott A. 2003. The cdk inhibitor p27Xic1 is required for differentiation of primary neurones in Xenopus. Development 130: 85-92.
152. Vernon AE, Movassagh M, Horan I, Wise H, Ohnuma S, Philpott A. 2006. Notch targets the Cdk inhibitor Xic1 to regulate differentiation but not the cell cycle in neurons. EMBO Rep 7: 643-648.
153. Vlachos P, Joseph B. 2009. The Cdk inhibitor p 57(Kip2) controls LIM-kinase 1 activity and regulates actin cytoskeleton dynamics. Oncogene 28: 4175-4188.
154. Wang W, Mouneimne G, Sidani M, Wyckoff J, Chen X, Makris A, Goswami S, et al. 2006. The activity status of cofilin is directly related to invasion, intravasation, and metastasis of mammary tumors. J Cell Biol 173: 395-404.
155. Watanabe H, Pan ZQ, Schreiber-Agus N, DePinho RA, Hurwitz J, Xiong Y. 1998. Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen. Proc Natl Acad Sci USA 95: 1392-1397.
156. Wu SX, Goebbels S, Nakamura K, Kometani K, Minato N, Kaneko T, Nave KA, et al. 2005. Pyramidal neurons of upper cortical layers generated by NEX-positive progenitor cells in the subventricular zone. Proc Natl Acad Sci USA 102: 17172-17177.
157. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704.
158. Yan Y, Frisen J, Lee MH, Massague J, Barbacid M. 1997. Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev 11: 973-983.
159. Ye W, Mairet-Coello G, Pasoreck E, Dicicco-Bloom E. 2009. Patterns of p57Kip2 expression in embryonic rat brain suggest roles in progenitor cell cycle exit and neuronal differentiation. Dev Neurobiol 69: 1-21.
160. Yokoo T, Toyoshima H, Miura M, Wang Y, Iida KT, Suzuki H, Sone H, et al. 2003. p57Kip2 regulates actin dynamics by binding and translocating LIM-kinase 1 to the nucleus. J Biol Chem 278: 52919-52923.
161. Yoshioka K, Foletta V, Bernard O, Itoh K. 2003. A role for LIM kinase in cancer invasion. Proc Natl Acad Sci USA 100: 7247-7252.
162. Zebda N, Bernard O, Bailly M, Welti S, Lawrence DS, Condeelis JS. 2000. Phosphorylation of ADF/cofilin abolishes EGF-induced actin nucleation at the leading edge and subsequent lamellipod extension. J Cell Biol 151: 1119-1128.
163. Zetterberg A, Larsson O, Wiman KG. 1995. What is the restriction point? Curr Opin Cell Biol 7: 835-842.
164. Zhang P, Liegeois NJ, Wong C, Finegold M, Hou H, Thompson JC, Silverman A, et al. 1997. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature 387: 151-158.
165. Zhang P, Wong C, DePinho RA, Harper JW, Elledge SJ. 1998. Cooperation between the Cdk inhibitors p27(KIP1) and p57(KIP2) in the control of tissue growth and development. Genes Dev 12: 3162-3167.
166. Zhang P, Wong C, Liu D, Finegold M, Harper JW, Elledge SJ. 1999. p21(CIP1) and p57(KIP2) control muscle differentiation at the myogenin step. Genes Dev 13: 213-224.
167. Zindy F, Cunningham JJ, Sherr CJ, Jogal S, Smeyne RJ, Roussel MF. 1999. Postnatal neuronal proliferation in mice lacking Ink4d and Kip1 inhibitors of cyclin-dependent kinases. Proc Natl Acad Sci USA 96: 13462-13467.
168. Zindy F, den Besten W, Chen B, Rehg JE, Latres E, Barbacid M, Pollard JW, et al. 2001. Control of spermatogenesis in mice by the cyclin D-dependent kinase inhibitors p18 (Ink4c) and p19(Ink4d). Mol Cell Biol 21: 3244-3255.
169. Zindy F, Soares H, Herzog KH, Morgan J, Sherr CJ, Roussel MF. 1997. Expression of INK4 inhibitors of cyclin D-dependent kinases during mouse brain development. Cell Growth Differ 8: 1139-1150.
170. Zindy F, van Deursen J, Grosveld G, Sherr CJ, Roussel MF. 2000. INK4d-deficient mice are fertile despite testicular atrophy. Mol Cell Biol 20: 372-378.